Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

RNAi therapy for spinocerebellar ataxia type 1

June 9, 2004

ProSavin improves motor function and clinical rating scales in parkinsonian macaques

June 9, 2004

BTG claims dual AChE/5-HT reuptake inhibitors for AD, depression, etc.

June 9, 2004

GSK researchers prepare and test two series of histamine H3 antagonists or inverse agonists

June 9, 2004

Two series of CGRP antagonists and their use in migraine and other disorders

June 9, 2004

Intranasal insulin improves memory function

June 9, 2004

Incara to revise phase I protocol for AEOL-10150

June 9, 2004

Alteplase filed for approval in Japan

June 9, 2004

European approval for Abilify for schizophrenia

June 9, 2004

Novel gabapentin prodrug with enhanced efficacy

June 9, 2004

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...